Where pharmaceutical assets become commercial reality.

Strategic business development, licensing and cross-border partnerships, from mandate to signed term sheet.

Who we work with

The right asset. The right partner. Executed.

Headquartered in Copenhagen, Generix partners with pharmaceutical manufacturers, Marketing Authorisation Holders (MAHs), dossier owners and commercial executives across international markets.

Successful partnerships take more than introductions. They depend on alignment across dossier readiness, regulatory pathways, supply reliability and deal economics. We pre-qualify counterparties and structure viable opportunities, so leadership teams can focus their capital and BD time where execution is most likely.

About Generix
Scientist working in a pharmaceutical laboratory
CDAProtected at
every stage
How we execute

From asset identification to signed agreement

01

Mandate & scoping

We define the commercial, technical and regulatory parameters: target territories, dossier formats (eCTD/CTD) and deal structure.

02

Targeted origination

Using our industry intelligence, we identify pre-vetted manufacturers, MAHs and counterparties that match your profile.

03

Qualified alignment

We manage CDA-protected introductions and feasibility discussions directly with the decision-makers.

04

Deal progression

We keep momentum through term sheet alignment, due diligence coordination and long-term partnership structuring.

What brings you here?

Tell us which side you are on

Buy-side & sourcing

I am looking for…

European eCTD dossiers, ready-to-market Rx/OTC products, reliable CMO manufacturing capacity, regional distribution partners or bolt-on acquisitions.

Submit a sourcing mandate
Sell-side & out-licensing

I have an opportunity…

Proprietary dossiers, out-licensing rights, commercialised MAs, specialised manufacturing capabilities or an asset for strategic divestment.

Present your asset

Product portfolio 2026

Our current portfolio of generic medicines, EU dossiers and oncology injectables is shared with qualified partners on request.

Request the portfolio

Accelerate your next transaction.

Whether you are expanding your therapeutic portfolio, monetising existing dossiers or entering new international territories, Generix brings the reach and discipline to execute.